title: Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors.
abstract: Laser ablation for low-risk primary penile tumors (Ta, Tis, and T1, preferably of low grade) offers satisfactory oncologic outcomes and excellent functional outcomes. Patients require long-term close surveillance given the substantial likelihood of local recurrence, and must adhere to strict follow-up protocols.
authors.affiliation: H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Leone
authors.affiliation: Duke Cancer Institute, Duke University, Durham, NC, USA.
authors.forename: Brant
authors.initials: B
authors.lastname: Inman
authors.affiliation: H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: philippe.spiess@moffitt.org.
authors.forename: Philippe E
authors.initials: PE
authors.lastname: Spiess
mesh_terms: D032921:Consensus; D019317:Evidence-Based Medicine; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects / Q000295:instrumentation*; D007834:Lasers / Q000009:adverse effects; D008297:Male; D009361:Neoplasm Invasiveness; D010412:Penile Neoplasms / Q000473:pathology / Q000601:surgery*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome